With a focus on molecular mechanisms and biomarker detection in neurodegenerative diseases, such as dystonia-parkinsonism and Alzheimer’s disease. With broad expertise in molecular assay design and validation, his work focuses on identifying and uncovering key molecular pathways that modify the progression of neurodegenerative diseases.
Dr. Rodichkin holds a joint appointment with the Brain, Behavior and the Environment program at Florida International University and is part of the Training in Environmental Neuroscience program, the first of its kind in the nation. His work and contributions to the field of neurotoxicology have been presented at numerous national and international conferences, such as Society for Toxicology and Society for Neuroscience. For his contributions to the field of metals neurotoxicology, Dr. Rodichkin has won multiple prestigious awards, with his work being published in well recognized journals, such as Neurobiology of Disease, Pharmacology & Therapeutics, and Neurotoxicology.
Dr. Rodichkin’s passion and interest in neurodegenerative diseases stems from a personal experience with dementia and parkinsonism. His commitment to investigate the intersection between environmental agents, neurotoxicology and the associated molecular mechanisms aims to not only broaden our understanding of the driving factors behind prevalent neurodegenerative diseases but also inform future therapeutic strategies and druggable targets.


